S P Steinberg
Overview
Explore the profile of S P Steinberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
773
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maple P, Haedicke J, Quinlivan M, Steinberg S, Gershon A, Brown K, et al.
Epidemiol Infect
. 2016 Mar;
144(11):2345-53.
PMID: 27018820
Healthcare workers (HCWs) reporting no history of varicella frequently receive varicella vaccination (vOka) if they test varicella-zoster virus (VZV) immunoglobulin G (IgG) negative. In this study, the utilities of VZV-IgG...
2.
Lafer M, Weckx L, de Moraes-Pinto M, Garretson A, Steinberg S, Gershon A, et al.
Clin Vaccine Immunol
. 2011 May;
18(7):1194-7.
PMID: 21613463
A flow cytometry-adapted fluorescent antibody to membrane antigen (FAMA) assay to detect IgG antibodies against varicella-zoster virus (VZV) was developed and tested in 62 serum samples, showing 90.32% accuracy obtained...
3.
McDonald S, Maple P, Andrews N, Brown K, Ayres K, Scott F, et al.
J Virol Methods
. 2011 Jan;
172(1-2):60-5.
PMID: 21192976
Determination of varicella zoster virus (VZV) immunity in healthcare workers without a history of chickenpox is important for identifying those in need of vOka vaccination. Post immunisation, healthcare workers in...
4.
Hambleton S, Steinberg S, Gershon M, Gershon A
J Virol
. 2007 May;
81(14):7548-58.
PMID: 17494071
The entry of inhaled virions into airway cells is presumably the initiating step of varicella-zoster infection. In order to characterize viral entry, we studied the relative roles played by lipid...
5.
Saiman L, LaRussa P, Steinberg S, Zhou J, Baron K, Whittier S, et al.
Infect Control Hosp Epidemiol
. 2001 Jun;
22(5):279-83.
PMID: 11428437
Objective: Varicella-zoster virus (VZV) vaccine is recommended to protect susceptible healthcare workers (HCWs) from serious disease and to prevent nosocomial spread of VZV. We evaluated clinical outcomes and serological responses...
6.
Vazquez M, LaRussa P, Gershon A, Steinberg S, Freudigman K, Shapiro E
N Engl J Med
. 2001 Mar;
344(13):955-60.
PMID: 11274621
Background: A live attenuated varicella vaccine was approved for use in the United States in March 1995 and is recommended for all susceptible persons 12 months of age or older....
7.
Sharrar R, LaRussa P, Galea S, Steinberg S, Sweet A, Keatley R, et al.
Vaccine
. 2000 Dec;
19(7-8):916-23.
PMID: 11115716
The postmarketing safety profile of varicella vaccine was evaluated by analyzing selected adverse experience reports temporally associated with the administration of the vaccine. There were 7963 reports voluntarily submitted to...
8.
LaRussa P, Steinberg S, Shapiro E, Vazquez M, Gershon A
Nat Med
. 2000 Dec;
6(12):1299-300.
PMID: 11100089
No abstract available.
9.
LaRussa P, Steinberg S, Shapiro E, Vazquez M, Gershon A
Pediatr Infect Dis J
. 2000 Dec;
19(11):1037-9.
PMID: 11099082
Background: Approximately 15% of recipients of live attenuated varicella vaccine may develop mild breakthrough varicella months to years after immunization. Although some vaccinees will develop zoster, it is less common...
10.
Kohl S, Rapp J, La Russa P, Gershon A, Steinberg S
Pediatr Infect Dis J
. 1999 Dec;
18(12):1112-3.
PMID: 10608641
No abstract available.